Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
12/2014
12/02/2014US8901365 Catalytic Wittig and Mitsunobu reactions
12/02/2014US8901339 Phosphonium salts and methods of their preparation
12/02/2014US8901338 Phosphonium salts and methods of their preparation
12/02/2014US8901333 Nanocrystals with functional ligands
12/02/2014US8901245 Rosin-derived cationic compounds and polymers
12/02/2014US8901218 Branched (meth)acrylate copolymer with high refractive index and method for preparing the same
12/02/2014US8901162 Substituted imidazolium compounds for treating disease
12/02/2014US8901140 6-amino quinazoline or 3-cyano quinoline derivatives, preparation methods and pharmaceutical uses thereof
12/02/2014US8901106 Imidazole prodrug LXR modulators
12/02/2014US8901105 Prodrug derivatives of (E)-N-methyl-N-((3-M ethylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
12/02/2014US8901047 Binders for binding beds and loose formations and processes for producing them
12/02/2014US8900550 Catalytic radiofluorination
11/2014
11/27/2014US20140350280 Extraction solvent control for reducing stable emulsions
11/27/2014US20140350268 Chiral imidodiphosphates and derivatives thereof
11/27/2014US20140350253 Asymmetric electrophilic fluorination using an anionic chiral phase-transfer catalyst
11/27/2014US20140350059 Novel oxazolidinone derivatives
11/27/2014US20140349973 Metalloenzyme inhibitor compounds
11/27/2014US20140349972 Substituted pyrimidines
11/27/2014US20140349970 Novel tricyclic compounds
11/27/2014US20140349368 Potent non-urea inhibitors of soluble epoxide hydrolase
11/25/2014US8895775 Method for preparing conjugated diene phosphonate compounds
11/25/2014US8895723 Methods of preparing substituted nucleotide analogs
11/25/2014US8895722 Splice-region antisense composition and method
11/25/2014US8895719 Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein
11/25/2014US8895531 2′-fluoronucleoside phosphonates as antiviral agents
11/25/2014US8895207 Materials and their use for the electrocatalytic evolution or uptake of H2
11/20/2014US20140343313 Method for making organodiphosphites from phosphorochloridites characterized by measuring side-product levels to determine further additions
11/20/2014US20140343017 Pyrrole compound
11/20/2014US20140341851 Novel benzimidazole derivatives
11/20/2014US20140339098 Process and catalyst for the electrochemical reduction of carbon dioxide
11/18/2014US8889884 Phosphine derivatives of fluorescent compounds
11/18/2014US8889879 Method for linking two or more metals for photo and electronic materials
11/18/2014US8889869 Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound
11/18/2014US8889862 2-amino-4-arylthiazole compounds as TRPA1 antagonists
11/18/2014US8889857 Phosphine-ligated palladium sulfonate palladacycles
11/18/2014US8889773 Metal phosphonate flame retardant and method producing thereof
11/18/2014US8889772 Method for producing mixtures of alkylphosphonous acid salts and dialkylphosphinic acid salts
11/18/2014US8889760 Photoactivatable crosslinker
11/18/2014US8889701 Substituted (S)-(2R,3R,5R)-3-hydroxy-(5-pyrimidin-1-yl)tetrahydrofuran-2-ylmethyl aryl phosphoramidate
11/18/2014US8889691 Indole compounds as an inhibitor of cellular necrosis
11/18/2014US8889658 Phosphonate compounds
11/13/2014US20140336408 Process for the manufacture of alkylamino alkylene phosphonic acids
11/13/2014US20140336137 Novel nitroso compounds as nitroxyl donors and methods of use thereof
11/13/2014US20140332470 Trimethylolpropane core, phosphonic acid terminated dendrimer and its preparation method
11/11/2014US8884071 Hydroformylation method having improved catalyst stability in reaction
11/11/2014US8884053 Method for the manufacture of aminoalkylene phosphonic acid
11/11/2014US8884011 Nucleotide analogues as precursor molecules for antivirals
11/11/2014US8884009 Process for making bortezomib and intermediates for the process
11/11/2014US8883765 Anti-cytomegalovirus activity of artemisinin-derived dimers
11/11/2014US8883764 Formylpyrrole-based heterocycles for nucleic acid attachment to supports
11/06/2014US20140330038 Method for producing phenylphosphonic acid metal salt composition, and crystal nucleating agent therefrom
11/06/2014US20140330006 Functionally-modified oligonucleotides and subunits thereof
11/06/2014US20140329989 Preparation of micafungin intermediates
11/04/2014US8877980 Phenylboronic acid
11/04/2014US8877957 Sythesis of P-chiral compounds
11/04/2014US8877956 1,3,2-dioxaphosphorinane, 2-sulfide derivatives for use as anti-wear additives in lubricant compositions
11/04/2014US8877947 Process for preparation of substantially pure fosamprenavir calcium and its intermediates
11/04/2014US8877908 Stimulus-responsive apta chelamers
11/04/2014US8877838 Melamine phenylphosphinate flame retardant compositions
11/04/2014US8877805 Heteroarylcarboxylic acid ester derivative
10/2014
10/30/2014US20140323749 Methods for the synthesis of 13c labeled plasmalogen
10/30/2014US20140323731 Lipidated imidazoquinoline derivatives
10/30/2014US20140323726 Methods for synthesizing molybdopterin precursor Z derivatives
10/30/2014US20140323703 Dark quenchers for donor-acceptor energy transfer
10/30/2014US20140323441 Purine derivatives for the treatment of viral infections
10/30/2014US20140323440 Amino-pyridine-containing spleen tyrosine kinase (syk) inhibitors
10/30/2014US20140323416 5-methyldihydromorphone compounds for treatment of pain
10/30/2014US20140323390 Compounds and compositions as tlr2 agonists
10/28/2014US8871974 Ionic liquid containing phosphonium cation having P—N bond and method for producing same
10/28/2014US8871973 Polyalkylene glycol producing catalyst, and method for producing polyalkylene glycol using same
10/28/2014US8871916 Diaryl phosphine compounds
10/28/2014US8871792 Neprilysin inhibitors
10/28/2014US8871785 Antiviral phosphonate analogs
10/28/2014US8871771 Salts of prodrugs of piperazine and substituted piperidine antiviral agents
10/28/2014US8871696 1,3,2-dioxaphosphorinane, 2-sulfide derivatives for use as anti-wear additives in lubricant compositions
10/28/2014US8871693 Volatile-phosphorus free gelling agents
10/23/2014US20140316533 Endosseous implant
10/23/2014US20140316154 Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
10/23/2014US20140316153 Extraction solvent control for reducing stable emulsions
10/23/2014US20140316118 Dark quenchers for donor-acceptor energy transfer
10/23/2014US20140315834 Compounds and compositions for use in the prevention and treatment of inflammation-related disorders, pain and fever, skin disorders, cancer and precancerous conditions thereof
10/21/2014US8865764 Compounds and methods for the treatment of cancer
10/21/2014US8865610 Phosphinyl guanidine compounds, metal salt complexes, catalyst systems, and their use to oligomerize or polymerize olefins
10/21/2014US8865321 Organic electroluminescent devices
10/16/2014US20140309453 Method for producing glufosinate p free acid
10/16/2014US20140309423 Novel organophosphorus compounds based on anthracenetriol
10/16/2014US20140309422 Dialkyl(2-alkoxy-6-aminophenyl)phosphine, the preparation method and use thereof
10/16/2014US20140309419 Method for enhancing the thermal stability of ionic compounds
10/16/2014US20140309413 Methods of stereoselective synthesis of substituted nucleoside analogs
10/16/2014US20140309321 Method of making hydroxymethylphosphonate, polyurethane foam-forming compositions, polyurethane foam and articles made therefrom
10/16/2014US20140309194 Therapeutic agent for arthrosis
10/16/2014US20140309193 Novel pyrrole derivatives
10/16/2014US20140309192 Modulators of the g protein-coupled mas receptor and the treatment of disorders related thereto
10/16/2014US20140309191 Salts, prodrugs and polymorphs of fab i inhibitors
10/16/2014US20140309190 Bicyclic aryl sphingosine 1-phosphate analogs
10/16/2014US20140309164 Deuterated nucleoside prodrugs useful for treating hcv
10/16/2014US20140308304 Lipids for the delivery of active agents
10/16/2014US20140308243 Hepatitis c virus inhibitors
10/14/2014US8859813 Ionic liquids having uronium cations and a process for making same
10/14/2014US8859799 Partially fluorinated phosphates
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 ... 554